Home
>
National Drug Code (NDC)
>
MALARONE
MALARONE - 0173-0675-02 - (atovaquone and proguanil hydrochloride)
Drug Information of MALARONE
| Product NDC: | 0173-0675 |
| Proprietary Name: | MALARONE |
| Non Proprietary Name: | atovaquone and proguanil hydrochloride |
| Active Ingredient(s): | 250; 100 mg/1; mg/1 & nbsp; atovaquone and proguanil hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of MALARONE
| Product NDC: | 0173-0675 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021078 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20000726 |
Package Information of MALARONE
| Package NDC: | 0173-0675-02 |
| Package Description: | 24 TABLET, FILM COATED in 1 DOSE PACK (0173-0675-02) |
NDC Information of MALARONE
| NDC Code | 0173-0675-02 |
| Proprietary Name | MALARONE |
| Package Description | 24 TABLET, FILM COATED in 1 DOSE PACK (0173-0675-02) |
| Product NDC | 0173-0675 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | atovaquone and proguanil hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20000726 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | ATOVAQUONE; PROGUANIL HYDROCHLORIDE |
| Strength Number | 250; 100 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Antimalarial [EPC],Antiprotozoal [EPC],Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA] |
